Patent details
91273 Product Name: "NATALIZUMAB OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES"(TYSABRI®)
Basic Information
- Publication number:
- 91273
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP909135980
- Legal Status:
- Expired
- Application number:
- 91273
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/006/346/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 27/06/2006
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 10/08/2006
- First Marketing Authorization date:
- 27/06/2006
- Grant date:
- 10/10/2006
- Activation date:
- 31/08/2010
- Publication date:
- 10/10/2006
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 31/08/2015
- SPC Extension Expiration:
- 31/08/2015
- Rejection date:
- Withdrawal date:
Owner
- From:
- 10/08/2006
- Name:
- FRED HUTCHINSON CANCER RESEARCH CENTER
- Address:
- PO Box 19024, SEATTLE,WA 98109-1024, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 10/08/2006
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- WAYNER Elizabeth
- Address:
- United States (US)
| Filing date | Document type | Number of pages |
|---|